AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 100 filers reported holding AKCEA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,000 | -5.3% | 2,017 | -25.7% | 0.00% | – |
| Q2 2020 | $38,000 | +8.6% | 2,716 | +10.5% | 0.00% | – |
| Q1 2020 | $35,000 | -28.6% | 2,459 | -15.0% | 0.00% | – |
| Q4 2019 | $49,000 | +32.4% | 2,892 | +19.1% | 0.00% | – |
| Q3 2019 | $37,000 | -35.1% | 2,429 | 0.0% | 0.00% | – |
| Q2 2019 | $57,000 | -17.4% | 2,429 | 0.0% | 0.00% | – |
| Q1 2019 | $69,000 | +3.0% | 2,429 | +8.6% | 0.00% | – |
| Q4 2018 | $67,000 | -15.2% | 2,237 | 0.0% | 0.00% | – |
| Q3 2018 | $79,000 | +75.6% | 2,237 | +17.8% | 0.00% | – |
| Q2 2018 | $45,000 | -34.8% | 1,899 | -29.8% | 0.00% | – |
| Q1 2018 | $69,000 | -1.4% | 2,705 | -32.0% | 0.00% | – |
| Q4 2017 | $70,000 | -36.9% | 3,976 | 0.0% | 0.00% | – |
| Q3 2017 | $111,000 | – | 3,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |